Showing chemical card for 6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid (CFc000158499)
6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid belongs to the class of organic compounds known as naphthopyranone glycosides. Naphthopyranone glycosides are compounds containing a carbohydrate moiety glycosidically linked to a naphthopyranone moiety. Based on a literature review very few articles have been published on 6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid.
MOL for CFc000158499 (6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid)
3D MOL for CFc000158499 (6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid)
3D SDF for CFc000158499 (6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid)
3D-SDF for CFc000158499 (6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid)
PDB for CFc000158499 (6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid)
3D PDB for CFc000158499 (6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid)
SMILES for CFc000158499 (6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid)
INCHI for CFc000158499 (6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid)
Structure for CFc000158499 (6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid)
3D Structure for CFc000158499 (6-({22-[(3,3-dimethyloxiran-2-yl)methyl]-5,7,8-trihydroxy-19,19-dimethyl-13-oxo-10-(prop-1-en-2-yl)-2,20-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,14,16(21),17-octaen-15-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid)
Belongs to the class of organic compounds known as naphthopyranone glycosides. Naphthopyranone glycosides are compounds containing a carbohydrate moiety glycosidically linked to a naphthopyranone moiety.
